Growth Metrics

Cerus (CERS) Shareholder's Equity Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Cerus 549.42 Mn 469.73 Mn 27.89 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 20.11%
Dec 31, 2025 14.18%
Sep 30, 2025 14.60%
Jun 30, 2025 11.67%
Mar 31, 2025 12.12%
Dec 31, 2024 6.46%
Sep 30, 2024 10.73%
Jun 30, 2024 -2.69%
Mar 31, 2024 -15.78%
Dec 31, 2023 -22.05%
Sep 30, 2023 -33.82%
Jun 30, 2023 -32.66%
Mar 31, 2023 -25.93%
Dec 31, 2022 -19.92%
Sep 30, 2022 -8.64%
Jun 30, 2022 -8.87%
Mar 31, 2022 -13.20%
Dec 31, 2021 -17.52%
Sep 30, 2021 -25.78%
Jun 30, 2021 -26.45%
Mar 31, 2021 -17.59%
Dec 31, 2020 81.95%
Sep 30, 2020 79.64%
Jun 30, 2020 74.50%
Mar 31, 2020 61.74%
Dec 31, 2019 -32.50%
Sep 30, 2019 -33.76%
Jun 30, 2019 -27.43%
Mar 31, 2019 -18.81%
Dec 31, 2018 117.05%
Sep 30, 2018 146.89%
Jun 30, 2018 130.19%
Mar 31, 2018 106.32%
Dec 31, 2017 -32.61%
Sep 30, 2017 -48.58%
Jun 30, 2017 -47.36%
Mar 31, 2017 -50.34%
Dec 31, 2016 -39.02%
Sep 30, 2016 -24.30%
Jun 30, 2016 -32.47%
Mar 31, 2016 -24.02%
Dec 31, 2015 128.23%
Sep 30, 2015 102.05%
Jun 30, 2015 150.02%
Mar 31, 2015 145.03%
Dec 31, 2014 -2.98%
Sep 30, 2014 32.63%
Jun 30, 2014 -19.54%
Mar 31, 2014 -26.19%
Dec 31, 2013 123.98%
Sep 30, 2013 110.72%
Jun 30, 2013 196.70%
Mar 31, 2013 214.83%
Dec 31, 2012 4.34%
Sep 30, 2012 4.63%
Jun 30, 2012 39.82%
Dec 31, 2011 -22.83%